The perioperative use of cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs may offer a safer alternative.
Reuben
Scott S
SS
Connelly
Neil R
NR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use*; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007527:Isoenzymes; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D008565:Membrane Proteins; D019106:Postoperative Hemorrhage / Q000139:chemically induced*; D011451:Prostaglandin-Endoperoxide Synthases; D013450:Sulfones; D014068:Tonsillectomy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D007783:Lactones; D008565:Membrane Proteins; D013450:Sulfones; C116926:rofecoxib; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases